Ultrasonic  ||| S:0 E:11 ||| JJ
frequency  ||| S:11 E:21 ||| NN
analysis  ||| S:21 E:30 ||| NN
for  ||| S:30 E:34 ||| IN
estimating  ||| S:34 E:45 ||| VBG
pH  ||| S:45 E:48 ||| JJ
in  ||| S:48 E:51 ||| IN
albumin-rich  ||| S:51 E:64 ||| JJ
biofluids  ||| S:64 E:74 ||| JJ
Ultrasound  ||| S:74 E:85 ||| NNP
is  ||| S:85 E:88 ||| VBZ
known  ||| S:88 E:94 ||| VBN
as  ||| S:94 E:97 ||| IN
a  ||| S:97 E:99 ||| DT
non-invasive  ||| S:99 E:112 ||| JJ
imaging  ||| S:112 E:120 ||| NN
modality  ||| S:120 E:129 ||| VBZ
capable  ||| S:129 E:137 ||| JJ
of  ||| S:137 E:140 ||| IN
propagating  ||| S:140 E:152 ||| NN
through  ||| S:152 E:160 ||| IN
highly  ||| S:160 E:167 ||| RB
scattering  ||| S:167 E:178 ||| JJ
media  ||| S:178 E:184 ||| NNS
such  ||| S:184 E:189 ||| JJ
as  ||| S:189 E:192 ||| IN
tissue ||| S:192 E:198 ||| NN
,  ||| S:198 E:200 ||| ,
blood ||| S:200 E:205 ||| NN
,  ||| S:205 E:207 ||| ,
and  ||| S:207 E:211 ||| CC
other  ||| S:211 E:217 ||| JJ
biological  ||| S:217 E:228 ||| JJ
fluids ||| S:228 E:234 ||| NNS
,  ||| S:234 E:236 ||| ,
yet  ||| S:236 E:240 ||| RB
currently  ||| S:240 E:250 ||| RB
provides  ||| S:250 E:259 ||| VBZ
little  ||| S:259 E:266 ||| JJ
chemical  ||| S:266 E:275 ||| NN
information ||| S:275 E:286 ||| NN
.  ||| S:286 E:288 ||| .
We  ||| S:288 E:291 ||| PRP
have  ||| S:291 E:296 ||| VBP
developed  ||| S:296 E:306 ||| VBN
a  ||| S:306 E:308 ||| DT
straightforward  ||| S:308 E:324 ||| JJ
and  ||| S:324 E:328 ||| CC
rapid  ||| S:328 E:334 ||| JJ
methodology  ||| S:334 E:346 ||| NN
for  ||| S:346 E:350 ||| IN
estimating  ||| S:350 E:361 ||| VBG
pH  ||| S:361 E:364 ||| JJ
in  ||| S:364 E:367 ||| IN
albumin-rich  ||| S:367 E:380 ||| JJ
biofluids  ||| S:380 E:390 ||| NNS
based  ||| S:390 E:396 ||| VBN
on  ||| S:396 E:399 ||| IN
analysis  ||| S:399 E:408 ||| NN
of  ||| S:408 E:411 ||| IN
ultrasonic  ||| S:411 E:422 ||| JJ
frequencies ||| S:422 E:433 ||| NN
.  ||| S:433 E:435 ||| .
Albumin  ||| S:435 E:443 ||| NNP
is  ||| S:443 E:446 ||| VBZ
the  ||| S:446 E:450 ||| DT
most  ||| S:450 E:455 ||| RBS
abundant  ||| S:455 E:464 ||| JJ
protein  ||| S:464 E:472 ||| NN
in  ||| S:472 E:475 ||| IN
serum  ||| S:475 E:481 ||| NN
and  ||| S:481 E:485 ||| CC
undergoes  ||| S:485 E:495 ||| JJ
conformational  ||| S:495 E:510 ||| JJ
changes  ||| S:510 E:518 ||| NNS
with  ||| S:518 E:523 ||| IN
pH ||| S:523 E:525 ||| JJ
.  ||| S:525 E:527 ||| .
It  ||| S:527 E:530 ||| PRP
was  ||| S:530 E:534 ||| VBD
shown  ||| S:534 E:540 ||| VBN
that  ||| S:540 E:545 ||| IN
when  ||| S:545 E:550 ||| WRB
ultrasound  ||| S:550 E:561 ||| JJ
propagated  ||| S:561 E:572 ||| NN
through  ||| S:572 E:580 ||| IN
albumin  ||| S:580 E:588 ||| JJ
solutions ||| S:588 E:597 ||| NNS
,  ||| S:597 E:599 ||| ,
the  ||| S:599 E:603 ||| DT
attenuation  ||| S:603 E:615 ||| NN
of  ||| S:615 E:618 ||| IN
collected  ||| S:618 E:628 ||| JJ
ultrasound  ||| S:628 E:639 ||| NN
signals  ||| S:639 E:647 ||| VBZ
increased  ||| S:647 E:657 ||| VBN
with  ||| S:657 E:662 ||| IN
pH ||| S:662 E:664 ||| JJ
.  ||| S:664 E:666 ||| .
By  ||| S:666 E:669 ||| IN
measuring  ||| S:669 E:679 ||| VBG
the  ||| S:679 E:683 ||| DT
ultrasound  ||| S:683 E:694 ||| NN
frequency  ||| S:694 E:704 ||| NN
spectra  ||| S:704 E:712 ||| NN
at  ||| S:712 E:715 ||| IN
several  ||| S:715 E:723 ||| JJ
albumin  ||| S:723 E:731 ||| JJ
concentrations  ||| S:731 E:746 ||| NNS
and  ||| S:746 E:750 ||| CC
pH  ||| S:750 E:753 ||| JJ
values ||| S:753 E:759 ||| NNS
,  ||| S:759 E:761 ||| ,
the  ||| S:761 E:765 ||| DT
pH  ||| S:765 E:768 ||| JJ
of  ||| S:768 E:771 ||| IN
the  ||| S:771 E:775 ||| DT
solutions  ||| S:775 E:785 ||| NNS
could  ||| S:785 E:791 ||| MD
be  ||| S:791 E:794 ||| VB
determined  ||| S:794 E:805 ||| VBN
by  ||| S:805 E:808 ||| IN
multilinear  ||| S:808 E:820 ||| JJ
regression ||| S:820 E:830 ||| NN
.  ||| S:830 E:832 ||| .
Differences  ||| S:832 E:844 ||| NNS
in  ||| S:844 E:847 ||| IN
absolute  ||| S:847 E:856 ||| JJ
protein  ||| S:856 E:864 ||| NN
content  ||| S:864 E:872 ||| NN
contributed  ||| S:872 E:884 ||| VBD
to  ||| S:884 E:887 ||| TO
signal  ||| S:887 E:894 ||| VB
differences  ||| S:894 E:906 ||| NNS
in  ||| S:906 E:909 ||| IN
the  ||| S:909 E:913 ||| DT
frequency  ||| S:913 E:923 ||| NN
profiles  ||| S:923 E:932 ||| NNS
and  ||| S:932 E:936 ||| CC
were  ||| S:936 E:941 ||| VBD
minimized  ||| S:941 E:951 ||| VBN
through  ||| S:951 E:959 ||| IN
normalization  ||| S:959 E:973 ||| NN
of  ||| S:973 E:976 ||| IN
each  ||| S:976 E:981 ||| DT
spectrum  ||| S:981 E:990 ||| NN
by  ||| S:990 E:993 ||| IN
the  ||| S:993 E:997 ||| DT
sum  ||| S:997 E:1001 ||| NN
of  ||| S:1001 E:1004 ||| IN
all  ||| S:1004 E:1008 ||| PDT
its  ||| S:1008 E:1012 ||| PRP$
frequency  ||| S:1012 E:1022 ||| NN
intensities ||| S:1022 E:1033 ||| NN
.  ||| S:1033 E:1035 ||| .
This  ||| S:1035 E:1040 ||| DT
strategy  ||| S:1040 E:1049 ||| NN
was  ||| S:1049 E:1053 ||| VBD
applied  ||| S:1053 E:1061 ||| VBN
to  ||| S:1061 E:1064 ||| TO
human  ||| S:1064 E:1070 ||| JJ
serum  ||| S:1070 E:1076 ||| JJ
samples  ||| S:1076 E:1084 ||| NNS
from  ||| S:1084 E:1089 ||| IN
multiple  ||| S:1089 E:1098 ||| JJ
donors ||| S:1098 E:1104 ||| NNS
,  ||| S:1104 E:1106 ||| ,
for  ||| S:1106 E:1110 ||| IN
which  ||| S:1110 E:1116 ||| WDT
a  ||| S:1116 E:1118 ||| DT
multilinear  ||| S:1118 E:1130 ||| JJ
regression  ||| S:1130 E:1141 ||| JJ
model  ||| S:1141 E:1147 ||| NN
was  ||| S:1147 E:1151 ||| VBD
developed  ||| S:1151 E:1161 ||| VBN
with  ||| S:1161 E:1166 ||| IN
a  ||| S:1166 E:1168 ||| DT
coefficient  ||| S:1168 E:1180 ||| NN
of  ||| S:1180 E:1183 ||| IN
determination  ||| S:1183 E:1197 ||| NN
( ||| S:1197 E:1198 ||| -LRB-
R ||| S:1198 E:1199 ||| NNP
( ||| S:1199 E:1200 ||| -LRB-
2 ||| S:1200 E:1201 ||| LS
) ||| S:1201 E:1202 ||| -RRB-
)  ||| S:1202 E:1204 ||| -RRB-
of  ||| S:1204 E:1207 ||| IN
0.93  ||| S:1207 E:1212 ||| NNP
and  ||| S:1212 E:1216 ||| CC
a  ||| S:1216 E:1218 ||| DT
standard  ||| S:1218 E:1227 ||| JJ
error  ||| S:1227 E:1233 ||| NN
of  ||| S:1233 E:1236 ||| IN
estimate  ||| S:1236 E:1245 ||| NN
( ||| S:1245 E:1246 ||| -LRB-
SEE ||| S:1246 E:1249 ||| NNP
)  ||| S:1249 E:1251 ||| -RRB-
of  ||| S:1251 E:1254 ||| IN
0.08  ||| S:1254 E:1259 ||| CD
pH  ||| S:1259 E:1262 ||| JJ
units ||| S:1262 E:1267 ||| NNS
.  ||| S:1267 E:1269 ||| .
The  ||| S:1269 E:1273 ||| DT
use  ||| S:1273 E:1277 ||| NN
of  ||| S:1277 E:1280 ||| IN
albumin  ||| S:1280 E:1288 ||| NN
as  ||| S:1288 E:1291 ||| IN
a  ||| S:1291 E:1293 ||| DT
pH  ||| S:1293 E:1296 ||| JJ
indicator  ||| S:1296 E:1306 ||| NN
opens  ||| S:1306 E:1312 ||| VBZ
the  ||| S:1312 E:1316 ||| DT
doors  ||| S:1316 E:1322 ||| NNS
for  ||| S:1322 E:1326 ||| IN
estimations  ||| S:1326 E:1338 ||| NN
in  ||| S:1338 E:1341 ||| IN
other  ||| S:1341 E:1347 ||| JJ
albumin-rich  ||| S:1347 E:1360 ||| JJ
media ||| S:1360 E:1365 ||| NNS
,  ||| S:1365 E:1367 ||| ,
such  ||| S:1367 E:1372 ||| JJ
as  ||| S:1372 E:1375 ||| IN
amniotic  ||| S:1375 E:1384 ||| JJ
fluid  ||| S:1384 E:1390 ||| NN
and  ||| S:1390 E:1394 ||| CC
cerebrospinal  ||| S:1394 E:1408 ||| JJ
fluid ||| S:1408 E:1413 ||| NN
.  ||| S:1413 E:1415 ||| .
